(6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
![(6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Structure](https://image.chemsrc.com/caspic/408/2944-87-8.png)
(6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one structure
|
Common Name | (6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | ||
|---|---|---|---|---|
| CAS Number | 2944-87-8 | Molecular Weight | 304.42400 | |
| Density | 1.19g/cm3 | Boiling Point | 479.8ºC at 760 mmHg | |
| Molecular Formula | C19H28O3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 258.1ºC | |
| Symbol |
GHS07, GHS08 |
Signal Word | Warning | |
| Name | (6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
|---|---|
| Synonym | More Synonyms |
| Density | 1.19g/cm3 |
|---|---|
| Boiling Point | 479.8ºC at 760 mmHg |
| Molecular Formula | C19H28O3 |
| Molecular Weight | 304.42400 |
| Flash Point | 258.1ºC |
| Exact Mass | 304.20400 |
| PSA | 57.53000 |
| LogP | 2.85000 |
| Vapour Pressure | 3.19E-11mmHg at 25°C |
| Index of Refraction | 1.578 |
| InChIKey | XSEGWEUVSZRCBC-QXROXWLYSA-N |
| SMILES | CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12 |
| Symbol |
GHS07, GHS08 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H312-H332-H351-H361 |
| Precautionary Statements | P280 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R20/21/22;R40;R63 |
| Safety Phrases | S22-S36 |
| RIDADR | NONH for all modes of transport |
|
~%
(6S,8R,9S,10R,1... CAS#:2944-87-8
Detail
|
| Literature: Steroids, , vol. 70, # 4 p. 327 - 333 |
![(6S,8R,9S,10R,13S,14S)-6-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione structure](https://image.chemsrc.com/caspic/432/24704-84-5.png)
| Precursor 1 | |
|---|---|
| DownStream 0 | |
|
Testosterone-metabolizing capacity and characteristics of adrenal microsomes in human fetus in vitro.
J. Pediatr. Endocrinol. Metab. 23(1-2) , 143-52, (2010) We describe the metabolite spectrum of testosterone (T) in human fetal adrenal in vitro, and verify possible roles of CYP3A and 2C isoforms of human fetal adrenal in T metabolism which respond to T me... |
|
|
The hepatic and intestinal metabolic activities of P450 in rats with surgery- and drug-induced renal dysfunction.
Pharm. Res. 20(10) , 1591-4, (2003) The hepatic and intestinal metabolic activities of P450 were evaluated in rats with surgery- and drug-induced renal dysfunction.Renal failure was induced by five-sixths nephrectomy (NR), bilateral ure... |
|
|
The use of heat treatment to eliminate drug interactions due to grapefruit juice.
Biol. Pharm. Bull. 29(11) , 2274-8, (2006) Grapefruit juice (GJ) contains components that may increase the bioavailability of drugs; however, approaches to the removal of these components have been little investigated. It is known that furanoc... |
| 6alpha-Hydroxytestosterone |
| 6-hydroxytestosterone |
| 4-androstene-6alpha,17beta-diol-3-one |
| Androst-4-ene-6|A,17|A-diol-3-one |
| 4-Androstene-6|A,17|A-diol-3-one |
| 6|A-Hydroxytestosterone |